Clinical Trials Browser

Phase NA × ruxolitinib × Clear all

NCT07454226 2026-03-06

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

Phase NA Not yet recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03274778 2025-11-18

Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells

Phase NA Withdrawn

Prostatic Neoplasms